Stuart Rae
25 Years at AB|32 Years of Experience
Stuart Rae is Chief Investment Officer of Emerging Markets Value Equities since 2023 and Chief Investment Officer of Asia-Pacific Value Equities, a position he has held since 2006. He is also a long-standing Portfolio Manager for China Equities. Previously, Rae was CIO of Australian Value Equities from 2003 to 2006. He joined the firm in 1999 as a research analyst covering the consumer sector, initially working in New York and London before moving to Sydney in 2003, Hong Kong in 2006 and Melbourne in 2021. Before that, Rae was a management consultant with McKinsey for six years in Australia and the UK. He holds a BSc (Hons) in physics from Monash University, Australia, and a DPhil in physics from the University of Oxford, where he studied as a Rhodes Scholar. Location: Melbourne
Published Work
China’s economy continues to struggle, but equity investors can find long-term opportunities in pockets of the markets.
As more Chinese companies get comfortable paying dividends, investors may find new sources of equity return potential.
There’s more to artificial intelligence (AI) than the US tech giants. Equity investors can find overlooked opportunities in emerging-market companies.
Investors in emerging-market equities haven’t typically paid much attention to the Middle East. It’s time to take a closer look.
There's a whiff of hope in the air across emerging markets. Recent equity market gains may signal the start of a broader recovery after years of underperformance.
Despite new challenges in emerging-market equities this year, value stocks have held up relatively well as changing conditions revive dormant recovery potential.
As China begins the year of the Ox, many investors are wondering whether another bull run is possible in 2021. Given that last year's rally was extremely narrow, we believe many parts of the market still offer pent-up recovery potential.
Chinese stocks have been resilient this year because of relatively modest earnings downgrades amid an early recovery from the virus-induced shock.
Tensions between the US and China are flaring up again. With pressure mounting on Chinese stocks listed in the US, including those widely held in emerging-market portfolios, investors need to consider how to prepare for the mounting risks.
Asian businesses are gradually rebooting after governments quelled the initial wave of the pandemic. Conditions may be improving for regional value stocks that were beaten down before and during the pandemic.
The current market outlook is bleak. But if the US and Europe take the right steps and follow China’s playbook, we believe the world could ultimately follow the Chinese markets’ road to recovery.
Growing fears about the coronavirus have hit Chinese stocks. While markets will remain unstable until China gets the outbreak under control, equity investors should revisit lessons from previous epidemics and consider the potential longer-term effects of the current crisis.
Now that the US and China have agreed to begin easing trade tensions, the fog over China's markets is starting to lift. Investors should consider Chinese equity opportunities that have been overlooked because of tariff fears.
China is the world's second-largest economy, but its equities are underrepresented in market indices and portfolios worldwide. With a growing stock market capitalization—and more inflows expected from greater index inclusion—foreign investors should take a closer look.
Complex ties between US and Chinese technology sectors are being tested by trade war tensions. But some steps taken by the US against Chinese multinational giant Huawei Technologies could backfire and spark a new phase of development for the Chinese technology sector.
China's rise as a preeminent economic power makes it impossible for globally minded investors to ignore. With the integration of China's domestic-listed equities and bonds into major global indices, the potential of investing in the broad economy is increasingly opening to the world.
African swine fever is ravaging China's pork supply and having a global impact on protein prices. For equity investors, the crisis serves as a reminder that even amid trade-war uncertainty, research into domestic trends can help investors access the country's vast stock market.
In the investing industry, we're all well aware that our business isn't a one-person endeavor. The basic problem-solving unit is quite often a group or team. But how do we create the right formula that ensures groups make thoughtful, effective decisions and avoid bad ones?
After MSCI decided today to boost the allocation to Chinese onshore stocks in its emerging-market indices, global investors are likely to pump more money into the market. But watch out for crowds. Flows into China are concentrated in a small group of large-cap stocks.
The Chinese stock market is changing at breathtaking speed and is on track to reach maturity faster than any other in history. Global investors have been reluctant to dive in, but there are good reasons to get acquainted with the companies serving the world's second-largest economy.
Leveraging diversity and maximising group effectiveness
Whenever the Chinese economy slows and its stocks take a serious hit, investors have come to expect the government to unleash large-scale fiscal and monetary stimulus. Another heaping spoonful of sugar may do more harm than good this time around, however. It's time for the ailing market to take some medicine.
In our many travels through China to explore the changing market landscape, we've discovered countless companies and industries that are jumping ahead of the West. These leapfroggers are creating exciting opportunities for investors as China's equity and debt markets open to the world.
President Trump's plans for tariffs on about $60 billion of Chinese imports have rattled equity markets. Investors should begin to study which types of industries, countries and companies could win or lose if an all-out trade war erupts.